Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-29

Clinical Trial Update: Personality and Quality of Life Amelioration After Continuous Subcutaneous Apomorphine Infusion in Parkinson's Disease

View source ↗

Summary

This ClinicalTrials.gov entry describes a recruiting study evaluating whether continuous subcutaneous infusion of apomorphine improves personality and quality o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Apomorphine (apomorphine)

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Parkinson Disease | Status: RECRUITING